About the Company
We do not have any company description for Schrodinger, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SDGR News
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger today reported that on April 15, 2024, the company granted (i) non-statutory stock options and (ii) restricted ...
Schrodinger and Takeda scientists discover new 3CLpro inhibitors
Researchers at Schrodinger Inc. and Takeda Pharmaceutical Co. Ltd. have described 3C-like proteinase (3CLpro; Mpro; nsp5) inhibitors reported to be useful for the treatment of coronavirus acute ...
5 Healthcare Stocks to Buy for 2024
Shares of biopharmaceutical firm Nuvectis (NASDAQ: NVCT) soared 200% after going public at $5 per share in 2022. Chris ...
Moderna and OpenAI in pact to fast-track drug development
Moderna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines.
6 Under-the-Radar AI Stocks That Analysts Expect to Rally
Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
7 Growth Stocks to Buy Now: Q2 Edition
Investing in growth stocks can deliver outsized gains, but investors have to stick with these stocks during volatile ...
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer
Congruence Therapeutics, a leading computationally-driven biotechnology company developing a pipeline of novel small molecules for diseases with significant unmet medical need, announced today the ...
Colorado companies begin groundwork for future moon economy
The Apollo missions to bring mankind to the moon for the first time more than 50 years ago is a small step in comparison to ...
9 Best Biotech ETFs for 2024
Biotechnology uses living organisms to develop new medicines and technologies that benefit both environmental and social ...
Materials informatics Market Size to Worth USD 1,572.93 Million by 2033
The global materials informatics market size is calculated at USD 252.9 million in 2024 and is estimated to be worth around USD 1,572.93 million by 2033, expanding at a notable CAGR of 23.05% from ...
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET Phase 2 ...
PSG And Barcelona Turned A Champions League Feast Into A Soggy Appetizer
If you were to look only at the raw facts of the matter, you might think Tuesday’s Champions League quarterfinal clash ...
Loading the latest forecasts...